Mecanismos de señalización celular en enfermedades hepáticas, cardiovasculares y cáncer
Centro Nacional de Biotecnología
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro Nacional de Biotecnología (9)
2022
-
Lack of EGFR catalytic activity in hepatocytes improves liver regeneration following DDC-induced cholestatic injury by promoting a pro-restorative inflammatory response
Journal of Pathology, Vol. 258, Núm. 3, pp. 312-324
2016
-
Dissecting the role of epidermal growth factor receptor catalytic activity during liver regeneration and hepatocarcinogenesis
Hepatology, Vol. 63, Núm. 2, pp. 604-619
2015
-
Programming controlled adhesion of E. coli to target surfaces, cells, and tumors with synthetic adhesins
ACS Synthetic Biology, Vol. 4, Núm. 4, pp. 463-473
-
p38 MAPK down-regulates fibulin 3 expression through methylation of gene regulatory sequences: Role in migration and invasion
Journal of Biological Chemistry, Vol. 290, Núm. 7, pp. 4383-4397
2014
-
Polμ deficiency increases resistance to oxidative damage and delays liver aging
PLoS ONE, Vol. 9, Núm. 4
2013
-
Proteasome activator complex PA28 identified as an accessible target in prostate cancer by in vivo selection of human antibodies
Proceedings of the National Academy of Sciences of the United States of America, Vol. 110, Núm. 34, pp. 13791-13796
2009
-
In vivo tumor targeting and imaging with engineered trivalent antibody fragments containing collagen-derived sequences
PLoS ONE, Vol. 4, Núm. 4
-
p53 regulates the self-renewal and differentiation of neural precursors
Neuroscience, Vol. 158, Núm. 4, pp. 1378-1389
2007
-
Inhibition of tumor growth in vivo by in situ secretion of bispecific anti-CEA × anti-CD3 diabodies from lentivirally transduced human lymphocytes
Cancer Gene Therapy, Vol. 14, Núm. 4, pp. 380-388